Positron Emission Tomography with Fluorodeoxyglucose for Primary Lymphoma of Bone |
Kim, Nam-Don
(Department of Interual Medicine, Korea Cancer Center Hospital)
Park, Yeon-Hee (Department of Interual Medicine, Korea Cancer Center Hospital) Ki, Seung-Seog (Department of Interual Medicine, Korea Cancer Center Hospital) Park, Yong-Jin (Department of Interual Medicine, Korea Cancer Center Hospital) Kim, Heoyng-Joon (Department of Interual Medicine, Korea Cancer Center Hospital) Ryoo, Baek-Yeol (Department of Interual Medicine, Korea Cancer Center Hospital) Kim, Heung-Tae (Department of Interual Medicine, Korea Cancer Center Hospital) Kim, Sung-Eun (Department of Nuclear Medicine, Korea Cancer Center Hospital) Cheon, Gi-Jeong (Department of Nuclear Medicine, Korea Cancer Center Hospital) Choi, Chang-Woon (Department of Nuclear Medicine, Korea Cancer Center Hospital) Lim, Sang-Moo (Department of Nuclear Medicine, Korea Cancer Center Hospital) |
1 | Mulligan ME, McRae GA, Murphey MD. Imaging features of primary lymphoma of bone. AJR 1999;173: 1691-7 DOI ScienceOn |
2 | Naumann R, Vaic A, Beuthien-Baumann B, Bredow J, Kropp J, Kittner T et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol 2001;115: 793-800 DOI ScienceOn |
3 | Daldrup-Link HE, Franzius C, Link TM, Laukamp D, Sciuk J, Jurgens H, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR 2001: 177:229-36 |
4 | Durr HR, Muller PE, Hiller E, Maier M, Baur A, Jansson V, et al. Malignant lymphoma of bone. Arch Orthop Trauma Surg 2002;122: 10-6 DOI PUBMED |
5 | Moog F, Kotzerke J, Reske SN. FDG PET can replace scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999;40:1407-13 PUBMED |
6 | Leeson MC, Makely JT, Carter JR, Krupco T. The use of radioisotope scans in the evaluation of primary lymphoma of bone. Orthop Rev 1989;18:410-6 PUBMED |
7 | Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic value than classical computed tomography scan imaging. Blood 1999;94: 429-33 PUBMED |
8 | Dubey P, Ha CS, Besa PC, Fuller L, Cabanillas F, Murray J, et al. Localized primary malignant lymphoma of bone. Int J Radia Oncol Biol Phys 1997;37: 1087-93 DOI ScienceOn |
9 | Parker F, Jackson H Jr. Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet 1939;68:43-5 |
10 | Hicks DG, Gokan T, O'Keefe RJ, Totterman SM, Fultz PJ, Judkins AR, et al. Primary lymphoma of bone. Cancer 1995;75: 973-80 DOI ScienceOn |
11 | Heyning FH, Hogendoorn PCW, Kramer MHH, Hermans J, Kluin-Nelemans JC, Noordijk EM, et al. Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 1999;13: 2094-8 DOI ScienceOn |
12 | Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, et al. Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Onco 2002;13: 1356-63 DOI ScienceOn |
13 | Huvos AG. Primary non-Hodgkin's lymphoma of bone. In: Huvos AG. Bone tumor diagnosis, treatment, and prognosis. 2nd ed. Philadelphia: Saunders Co;1991, p. 625-37 |
14 | Barr J, Burkes RL, Bell R, Blackstein ME, Fernandes B, Langer F. Primary non-Hodgkin's lymphoma of bone. Cancer 1994;73: 1194-9 DOI ScienceOn |
15 | Romer W, Hanauske AR, Ziegler S, Thodtmann R, Weber W, Fuchs C, et al. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose.Blood 1998;91: 4464-71 PUBMED |